Compare · ACLL vs BIS
ACLL vs BIS
Side-by-side comparison of ACell, Inc. (ACLL) and ProShares UltraShort Nasdaq Biotechnology (BIS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ACLL and BIS operate in n/a (n/a), so they compete in similar markets.
ProShares UltraShort Nasdaq Biotechnology
The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
Latest ACLL
No recent items for ACell, Inc..